BIO International Convention 2026 Exhibitor Preview: Biotechnology Leaders and Services

The BIO International Convention 2026 is set to convene from June 22-25 at the San Diego Convention Center in San Diego, California, USA. Recognized as the largest and most comprehensive event for biotechnology worldwide, it serves as a crucial gathering point for approximately 20,000 industry leaders, innovators, and investors from across the globe. The convention's expansive scope covers the full spectrum of the biotech ecosystem, making it a pivotal event for networking and discovering new trends.

Attendees can anticipate a program rich with discussions on cutting-edge topics. Scheduled focus areas for 2026 include advancements in AI and Digital Health, critical insights into Biomanufacturing, emerging research in Brain Health, strategies for Business Development and Investment, the latest in Cell and Gene Therapy and Genome Editing, and developments in Diagnostics and Personalized Medicine. This diverse agenda underscores the convention's role in shaping the future of biotechnology.

Understanding the Exhibitor Landscape

Our preview of the BIO International Convention 2026 exhibitor landscape is based on information gathered from official event resources and industry insights, focusing on the types of companies typically present at such a comprehensive biotechnology event. We aim to provide a categorical overview of expected participants, detailing their company name, headquarters country (where information is publicly available), and their primary product category label.

Key Exhibitor Categories at BIO International Convention 2026

The convention is a magnet for companies representing various facets of the biotechnology and biopharmaceutical industries. From global pharmaceutical giants to specialized service providers and innovative research firms, the exhibitor floor promises a rich tapestry of expertise.

Biopharmaceuticals and Therapeutics

This category includes companies focused on the discovery, development, and commercialization of biological products and therapeutic solutions. Many are at the forefront of addressing complex health challenges through advanced biotechnological approaches.

• AbbVie: Global biopharmaceutical company
• 3SBio Inc.: Biopharmaceuticals/Therapeutics
• AAARNA Therapeutics Pvt Ltd: Therapeutics
• 9Bio Therapeutics/Nanofacile: Therapeutics/Nanotechnology
• A&O Pharma GmbH: Pharmaceuticals
• 4basecare Precision Health Pvt Ltd: Precision Health/Therapeutics

Biopharmaceutical Contract Services (CDMO, Clinical Trials, Consulting)

A significant portion of the biotech ecosystem relies on specialized contract services for development, manufacturing, and clinical support. These firms are essential partners in bringing new innovations to market.

• biomay: Vienna, Austria; Biopharmaceutical Contract Development and Manufacturing Organization (CDMO)
• PCI Pharma Services: Pharmaceutical Contract Services
• 3D Pharma Consulting Ltd: Pharmaceutical Consulting
• AAPharmaSyn, LLC: Pharmaceutical Synthesis/Research
• A2 Healthcare: Healthcare Services
• 3PBIOVIAN: Biologics/Biomanufacturing
• 53Biologics: Biologics

Digital Health and Analytics

As technology continues to merge with healthcare, companies specializing in digital solutions, data analytics, and AI are becoming increasingly vital. Their offerings support everything from drug discovery to patient management.

• GlobalData: Market Intelligence and Data Analytics
• AB DigiHealth Inc.: Digital Health

Research and Biotechnology Tools

These exhibitors provide the foundational tools, reagents, and research services that enable scientific discovery and development across the biotechnology landscape.

• REPROCELL: Drug Discovery and Research Reagents/Services
• 2bind GmbH: Biotechnology Research/Services
• 3DforScience-Global Scientific Communications: Scientific Communications
• AB ANALITICA: Diagnostics/Analytics
• 2T Labs LLC: Biotechnology/Research
• 6J Biotechnology (Hong Kong) Limited: Hong Kong; Biotechnology

The BIO International Convention 2026 offers an unparalleled opportunity to engage with these and many other companies shaping the future of biotechnology. Which of these exhibitor categories or specific companies piques your interest the most for the upcoming convention?